Abstract:
Systemic Lupus Erythematosus (SLE), commonly known as lupus, presents a
complex autoimmune challenge where the immune system mistakenly targets healthy
tissues. Excessive immune responses can lead to the immune system attacking organs
and tissues. This compromised immune system makes individuals more susceptible
to infections, and immunosuppressive medications can heighten this risk. This study
strives to unravel the intricate biological pathways associated with SLE, utilizing advanced bioinformatics and systems biology methods. The far-reaching impact of SLE
on various organ systems, often leading to debilitating symptoms and reduced quality
of life, highlights the urgency of this research. The major issue at hand is comprehending the underlying molecular mechanisms of SLE, with a particular focus on gene
expression patterns across diverse organ systems. SLE complexity lies in its varied
clinical manifestations and the variation in gene expression observed among affected
individuals. Moreover, inflammatory processes driven by immune cell dysfunction,
specifically the TH1 and TH2 cell pathways responsible for T-helper cell differentiation, significantly contribute to the disease progression. To address this challenge, a
thorough analysis of diverse datasets was conducted, encompassing microarray, RNAseq and single cell data to examine gene expression patterns across various organ
systems affected by SLE. Notably, the absence of commonly differentially
expressed genes across datasets directed attention to single-cell data, valued for its
ability to reveal subtle insights. Thorough examination of the expression patterns of
critical genes such as Gata3, C-Maf, IFN-gamma, IL-2, IL-4, IL-5/IL-13, and
IL2Ra/IL4Ra was undertaken across various concentrations using systems biology
approach. These examinations yielded valuable insights into the roles of these genes
in the onset and progression of SLE. Genes such as IL-2 and Gata3, were particular
interest in which exhibited unusual behavior as the response increased from immune
system, prompting an in-depth examination of their roles in the disease progression.
Further-
2
Abstract
more, a sophisticated machine learning model was developed to categorize peptides
based on their affinity for binding to immune cells, such as B cells, T cells, and Major Histocompatibility Complex (MHC) molecules. Ensuring the model’s accuracy
involved employing rigorous data preprocessing techniques. This model exhibited
exceptional precision and accuracy (59%) in classifying peptides into three distinct
groups, rigorously validated using an independent test dataset. These findings
significantly enhance the understanding of the intricate molecular aspects underlying
SLE. They illuminate gene expression patterns and peptide binding characteristics,
establishing a robust foundation for potential therapeutic interventions and
advancements in lupus diag- nostics. Future prospects encompass ongoing research
to refine our understanding of SLE and develop more targeted and effective
treatments, ultimately enhancing the quality of life for individuals grappling with
this intricate autoimmune disorder.